Related Experiment Video
Updated: Jan 12, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Predictive Factors Associated With Multidrug-Resistant Tuberculosis Among Tuberculosis Patients in Southwest
Sileshi Meseret Goshiye1, Lamesa Dube1, Solomon Berhanu Mogas1
1Department of Epidemiology & Biostatistics, Faculty of Public Health Jimma University Jimma Ethiopia.
Background:
Multidrug-resistant tuberculosis (MDR-TB) presents a significant public health challenge, particularly in resource-limited settings like Ethiopia. Identifying factors associated with MDR-TB is essential for designing effective control strategies. The objective of this study was to identify the determinants of multidrug-resistant tuberculosis (MDR-TB) in southwest Ethiopia, to inform targeted public health interventions, improve prevention and control strategies, and support evidence-based planning in regions with limited resources and a high burden of drug-resistant TB.
Methods:
An unmatched case-control study was conducted from October 2022 to February 2023 in Jimma and Illubabor zones, located in Southwest Ethiopia. A total of 201 participants were initially selected, of whom 200 (66 MDR-TB cases and 134 drug-susceptible TB controls) completed the study and were included in the final analysis. Data were collected through interviewer-administered questionnaires and review of medical records. Variables with a p-value < 0.25 in bivariable analysis were entered into multivariable logistic regression to identify independent predictors of MDR-TB. Adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were used, and statistical significance was declared at p < 0.05.
Results:
Among the 200 participants included, several factors were significantly associated with MDR-TB. Compared to those aged 15-24 years, participants aged 25-34 years (AOR = 3.8, 95% CI: 1.34-8.36) and 35-44 years (AOR = 3.3, 95% CI: 1.42-7.65) had higher odds of MDR-TB. Other significant predictors included urban residence (AOR = 2.1), contact with TB or known MDR-TB patients (AOR = 2.21), HIV infection (AOR = 1.9), substance use (alcohol, khat, illicit drugs), psychological illness (AOR = 9.4), previous TB treatment (AOR = 5.3), retreatment history (AOR = 13.9), low BMI (< 18.5 kg/m²; AOR = 3.9), living more than 25 km from treatment centers (AOR = 6.2), and perceived social stigma (AOR = 5.2).
Conclusion:
This study identified multiple independent predictors of MDR-TB, including previous TB treatment, retreatment history, substance use, HIV infection, psychological illness, malnutrition, and limited access to healthcare. Sociodemographic factors such as age, urban residence, and perceived stigma were also significant. These findings highlight the need for integrated TB control strategies addressing clinical management, behavioral and psychosocial support, and improved healthcare access to effectively reduce MDR-TB in Southwest Ethiopia.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Therapeutic Drug Monitoring: Affecting Factors
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

